Elsie Biotechnologies
Richard Redman is an experienced chemist with a strong background in organic chemistry and a Ph.D. from Brandeis University. Currently serving as Senior Scientist II at Elsie Biotechnologies, Richard has progressed through multiple roles within the company since May 2022, including Senior Scientist I and Scientist in Chemistry. Prior to this, Richard held the position of Scientist in Organic/Oligonucleotide Synthesis at OliX Pharmaceuticals, Inc. from August 2021 to May 2022. Richard also contributed to research as an Organic Chemistry PhD student at Brandeis University from August 2016 to August 2021, and worked as a Research Associate II at Integrity Bio and as a Laboratory Technician at Promega earlier in the career. Richard earned a Bachelor of Science in Biochemistry from California Polytechnic State University-San Luis Obispo in 2014.
This person is not in any teams
This person is not in any offices
Elsie Biotechnologies
Elsie’s technology relies on a three dimensional platform that allows for the synthesis, deconvolution, and delivery of homogeneous oligonucleotide therapeutics. Our hope to leverage an out of the box way of thinking as well as a multidisciplinary approach to bring safer and more efficacious therapeutics to the market to treat the most intractable human diseases.